93 Followers on Owler

Xencor

is a California-based biopharmaceutical company that discovers and develops monoclonal antibody and cytokine therapy for the treatment of asthma diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Xencor

is a California-based biopharmaceutical company that discovers and develops monoclonal antibody and cytokine therapy for the treatment of asthma diseases... Read more
Xencor President & CEO: Bassil I. Dahiyat

President & CEO

Bassil I. Dahiyat

CEO Approval Rating

86/100

1997

PublicNASDAQXNCR

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$110.5M
Employees
280
Funding
$799.1M
Investments
1

News

Funding
Sep 13, 2024
Business Wire
Xencor received $201.3M in Post-IPO Equity Funding

Xencor Competitors

1Zymeworks
2Merus
3MacroGenics
4Amgen
5Regeneron
6Genmab
7PTC
8Altor BioScience
9UCSF
10Five Prime
Unlock 30 + competitors

Trending Companies